Sign In
Buy IMCR
$29.20
-0.150 (-0.511%)
At Close: Jun 23, 2026
What Makes Immunocore Holdings PLC Sponsored ADR (IMCR) a Good Fit for "Trend Investing"
10:32am, Thursday, 10'th Nov 2022
If you are looking for stocks that are well positioned to maintain their recent uptrend, Immunocore Holdings PLC Sponsored ADR (IMCR) could be a great choice. It is one of the several stocks that pass
Immunocore to present at the Jefferies London Healthcare Conference
07:00am, Thursday, 10'th Nov 2022
Immunocore to present at the Jefferies London Healthcare Conference
Why Immunocore (IMCR) Might Surprise This Earnings Season
10:32am, Tuesday, 08'th Nov 2022
Immunocore (IMCR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Strength Seen in Immunocore Holdings PLC Sponsored ADR (IMCR): Can Its 10.2% Jump Turn into More Strength?
12:02pm, Wednesday, 26'th Oct 2022
Immunocore Holdings PLC Sponsored ADR (IMCR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving hi
Wall Street Analysts Believe Immunocore Holdings PLC Sponsored ADR (IMCR) Could Rally 60%: Here's is How to Trade
11:17am, Tuesday, 11'th Oct 2022
The consensus price target hints at a 60.4% upside potential for Immunocore Holdings PLC Sponsored ADR (IMCR). While empirical research shows that this sought-after metric is hardly effective, an upwa
Immunocore: Attractive Commercial-Stage Biopharma
12:36pm, Wednesday, 05'th Oct 2022
Immunocore Holdings plc has one asset already in the market. It has a pipeline of TCR bispecific molecules targeting various indications.
Bet on These 4 Biotech Stocks With Bright Prospects
10:32am, Wednesday, 28'th Sep 2022
New drug approvals and pipeline development should maintain momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and pipeline progress position AGEN, CVAC, IMCR and DVAX well am
Is Immunocore (IMCR) Stock Outpacing Its Medical Peers This Year?
11:18am, Thursday, 22'nd Sep 2022
Here is how Immunocore Holdings PLC Sponsored ADR (IMCR) and vTv Therapeutics (VTVT) have performed compared to their sector so far this year.
You can start to dip your toes into biotech here, says Jefferies' Yee
04:25pm, Friday, 02'nd Sep 2022
Jefferies' Michael Yee joins 'Closing Bell' to discuss biotech stocks, which were one of the worst performers in today's sell-off. With CNBC's Michael Santoli.
Does Immunocore Holdings PLC Sponsored ADR (IMCR) Have the Potential to Rally 45% as Wall Street Analysts Expect?
11:17am, Wednesday, 31'st Aug 2022
The consensus price target hints at a 44.9% upside potential for Immunocore Holdings PLC Sponsored ADR (IMCR). While empirical research shows that this sought-after metric is hardly effective, an upwa
Here's Why Momentum in Immunocore Holdings PLC Sponsored ADR (IMCR) Should Keep going
10:32am, Wednesday, 31'st Aug 2022
Immunocore Holdings PLC Sponsored ADR (IMCR) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the
What Makes Immunocore Holdings PLC Sponsored ADR (IMCR) a Strong Momentum Stock: Buy Now?
01:32pm, Monday, 29'th Aug 2022
Does Immunocore Holdings PLC Sponsored ADR (IMCR) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is Immunocore (IMCR) Stock Outpacing Its Medical Peers This Year?
11:18am, Thursday, 18'th Aug 2022
Here is how Immunocore Holdings PLC Sponsored ADR (IMCR) and Bellicum Pharmaceuticals (BLCM) have performed compared to their sector so far this year.
Here's Why "Trend" Investors Would Love Betting on Immunocore Holdings PLC Sponsored ADR (IMCR)
10:32am, Monday, 15'th Aug 2022
Immunocore Holdings PLC Sponsored ADR (IMCR) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many sto
Immunocore Holdings (IMCR) CEO Bahija Jallal on Q2 2022 Results - Earnings Call Transcript
02:55pm, Wednesday, 10'th Aug 2022
Immunocore Holdings (NASDAQ:IMCR ) Q2 2022 Earnings Conference Call August 9, 2022 8:00 AM ET Company Participants Clayton Robertson - Head, IR Bahija Jallal - CEO & Director Brian Di Donato - CFO & H
